| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 3 |
| 1 | APIXABAN | 2 |
| 2 | LOSARTAN | 2 |
| 3 | NIRAPARIB | 2 |
| 4 | NIVOLUMAB | 2 |
| 5 | PEMBROLIZUMAB | 2 |
| 6 | SITAGLIPTIN | 2 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 9 | ADALIMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 1 | RIPRETINIB | 1 | 0.0002 |
| 2 | ERGOCALCIFEROL | 3 | 0.0001 |
| 3 | NIRAPARIB | 2 | 0.0001 |
| 4 | REGORAFENIB | 1 | 0.0001 |
| 5 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 6 | AXITINIB | 1 | 0.0001 |
| 7 | TRAMETINIB | 1 | 0.0000 |
| 8 | LENVATINIB | 1 | 0.0000 |
| 9 | APIXABAN | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 2 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Sulfonylurea [EPC] | 1 | 0.0000 |
| 7 | Factor Xa Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |